Bryan M. Reasons Insider Trading $AMRX Amneal Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bryan M. Reasons.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bryan M. Reasons. Bryan M. Reasons is Chief Financial Officer in IMPAX LABORATORIES INC ($IPXL) and Director in Aclaris Therapeutics, Inc. ($ACRS) and EVP & CFO in Mallinckrodt plc ($MNK) and Director in Recro Pharma, Inc. ($REPH) and CFO in Amneal Pharmaceuticals, Inc. ($AMRX).
Bryan M. Reasons in Amneal Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: CFO
Holdings: 82,986 shares
Latest Transaction: Aug 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Bryan M. Reasons in Amneal Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AMRX, IPXL, MNK, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Sell | S | 23.65 | 11,698 | 276,658 | 82,986 | 94.7 K to 83 K (-12.35 %) |
| Aug 23 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Sell | S | 23.65 | 11,698 | 276,658 | 82,986 | 94.7 K to 83 K (-12.35 %) |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 0.00 | 33,311 | 0 | 33,311 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 15.01 | 136,240 | 2,044,962 | 136,240 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 17.99 | 52,000 | 935,480 | 52,000 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 25.24 | 55,000 | 1,388,200 | 55,000 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 40.70 | 47,500 | 1,933,250 | 47,500 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 33.27 | 63,095 | 2,099,171 | 63,095 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Grant | A | 0.00 | 94,684 | 0 | 94,684 | 0 to 94.7 K |
Page: 1